Alphatec Holdings enters the final stretch before its July 31 earnings report with a striking contradiction: the stock is up 8.4% on the week and 17% over the past month, yet the Street just cut its target again and the prior quarter produced a 32% single-day collapse.
The Street's posture this week is cautious but not bearish. Stifel trimmed its target to $13 from $16 on July 8 while keeping a Buy rating — a fresh signal that even bulls are recalibrating after the May earnings disaster. The broader analyst community still tilts constructively, with the consensus mean target around $16.45, but that number is dragged up by several stale post-Q1 cuts: Barclays, Wells Fargo, JP Morgan, and others slashed targets from the mid-to-high $20s down to the low-to-mid teens in early May. No one has upgraded. The bull case rests on valuation — ATEC trades cheaply on an EV-to-sales basis versus spine device peers — and on EPS estimate momentum that ranks in the 89th and 92nd percentiles on 30- and 90-day windows respectively. The bear case is execution: the EOS imaging business missed badly, guidance came down sharply, and the company generates no free cash flow, which limits its margin for error heading into the next print.
The lending market is relaxed, and that absence of squeeze pressure is itself informative. Short interest at 8.5% of the free float is meaningful, but it has been falling — down roughly 10.6% over the past month, from above 14 million shares in early June to around 12.6 million now. The borrow cost has also eased, to roughly 0.43%, roughly 17% below where it sat a week ago. Availability is running at about 705% of current short interest, comfortably in the normal range and well above the 52-week low of 311%. Bears are trimming, not piling in. Options traders are equally unexcited: the put/call ratio is 0.56, barely above its 20-day average of 0.54 and less than one standard deviation from the mean. There is no unusual defensiveness being priced into the options market ahead of the July 31 date. Together, the positioning signals suggest shorts are unwinding into the rally rather than pressing it.
The earnings history makes July 31 the most important date on the calendar. The May 5 Q1 report was catastrophic — ATEC fell 32% the next day and was still down 25% five days later. The prior Q4 print showed a more modest -2% next-day reaction, but the stock had given back 33% by the end of that week. Two data points is a thin sample, but the pattern is lopsided: the stock has not rewarded holders into results. The current rally, which has taken shares back to $9.38 from the post-May-crash lows, is recovering ground lost in the aftermath of that print. The ORTEX short score of 52.4 is mid-range and has been flat over the past two weeks, suggesting the short-side community sees the current setup as balanced rather than skewed.
Institutional ownership adds one note of interest. Point72 added nearly 1.4 million shares in Q1 — the largest incremental buyer among the reported top holders — while Royal Bank of Canada trimmed by 464,000 shares. Director Keith Valentine made three separate open-market purchases in early May at prices between $7.00 and $7.54, spending roughly $996,000 across the cluster; that buying came directly into the post-earnings wreckage and is the most substantive insider signal in the recent record. The 90-day net insider figure is a modest positive in share terms, though the March selling by the COO and CFO at prices north of $12 adds nuance to the picture.
With the next earnings print three weeks out, the question is whether the July rally is recovering lost ground or getting ahead of a company that still needs to demonstrate EOS is back on track.
See the live data behind this article on ORTEX.
Open ATEC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
